Skip to main content
SpringerLink
Log in

EDICT policy recommendations support protection of research participants

  • Published:
Journal of Cancer Education Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Protection of Human Subjects. 45 CFR §46, 2005. Available at: www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm. Accessed October 20, 2008.

  2. NIH Revitalization Act of 1993. Publ. No. 103-43. 1993.

  3. DHHS, FDA. Investigational New Drug Applications and New Drug Applications. 21 CFR Parts 312 and 314. Federal Register, Volume 63, February 11, 1998, page 6854. AND Guidance for Industry. Collection of Race and Ethnicity Data in Clinical Trials. Available at: http:// www.fda.gov/cder/guidance/5656fnl.htm. Accessed November 3, 2008.

  4. Research on Cardiovascular Disease in Women Program Brief. Agency for Healthcare Research and Quality, June 2006. Available at: http:// www.ahrq.gov/research/womheart.htm. Accessed October 10, 2008.

  5. Gender disparity seen in medical trials. United Press International article on remarks by Dr. Wendy Tsang at the Canadian Cardiovascular Congress 2008 in Toronto. Available at: www.upi.com/ Health_News/2008/20/28/Gender_disparity_seen_in_medical_trials/ UPI-53701225208817/. Accessed November 5, 2008.

  6. United States General Accounting Office. GAO-01-286R. Drugs Withdrawn From Market. January 19, 2001. Available at: www.gao.gov/new.items/d01286r.pdf. Accessed October 15, 2008.

  7. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med. 1996;2:1184–1185.

    Article  Google Scholar 

  8. FDA Approves BiDil Heart Failure Drug for Black Patients. June 23, 2005. Available at: http://www.fda.gov/bbs/topics/NEWS/2005/ NEW01190.html. Accessed September 30, 2008.

  9. DHHS, FDA, Center for Drug Evaluation and Research. Cardiovascular and Renal Drugs Advisory Committee transcript, June 15, 2005. Available at: www.fda.gov/ohrms/dockets/ac/05/transcripts/2005-4145T1.pdf. Accessed October 17, 2008.

  10. Uhl K, Marts S. Assessing sex differences: methodological considerations. Expert Rev Clin Pharmacol. 2008;1:585–587.

    Article  Google Scholar 

  11. Du W, Gadgeel SM, Simon MS. Predictors of enrollment in lung cancer clinical trials. Cancer. 2006;106:420–425.

    Article  PubMed  Google Scholar 

  12. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14:3328–3334.

    Article  PubMed  Google Scholar 

  13. Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, Brawley OW, Gross CP, Emanuel E. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3:e19.

    Article  PubMed  Google Scholar 

  14. Fouad MN, Corbie-Smith G, Curb D, Howard BV, Mouton C, Simon M, Talavera G, Thompson J, Wang CY, White C, Young R. Special populations recruitment for the Women’s Health Initiative: successes and limitations. Control Clin Trials. 2004;25:335–352.

    Article  PubMed  Google Scholar 

  15. Baylor College of Medicine—Eliminating Disparities in Clinical Trials (EDICT). Major deficiencies in the design and funding of clinical trials: a report to the nation on how human studies are conducted. Findings of the Eliminating Disparities in Clinical Trials Project (EDICT). Available at: www.bcm.edu/edict/PDF/EDICT_ Project_White_Paper.pdf. Accessed October 10, 2008.

Download references

Author information

Authors and Affiliations

  1. Department of Health & Human Services, Office of Public Health & Science, 200 Independence Ave, Room 716G, 20201, Washington, DC

    Wanda K. Jones DrPH

Authors
  1. Wanda K. Jones DrPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wanda K. Jones DrPH.

Additional information

Dr. Wanda K. Jones is Principal Deputy Assistant Secretary for Health (Women’s Health).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, W.K. EDICT policy recommendations support protection of research participants. J Canc Educ 24 (Suppl 2), S52–S53 (2009). https://doi.org/10.1007/BF03182313

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03182313

Keywords

Search

Navigation